Europe may face double dip recession as second wave of Covid cases rise – leading macroeconomic influencers 20 Oct 2020
Drug Development Neutralising the gluten threat: are we on the cusp of a coeliac disease breakthrough? 20 Oct 2020
Drug Development Neutralising the gluten threat: are we on the cusp of a coeliac disease breakthrough? 20 Oct 2020
Drug Development Neutralising the gluten threat: are we on the cusp of a coeliac disease breakthrough? 20 Oct 2020
22 Jul 2020 Comment AstraZeneca successfully clears out the first trial for the Covid-19 vaccine, boosting its share price 22 Jul 2020
11 Jun 2020 Comment AstraZeneca and Gilead Sciences merger would be the biggest in the pharma history 11 Jun 2020
23 Mar 2020 Comment Covid-19 epidemic will reshape patient behaviour, accelerating digitalisation of healthcare system 23 Mar 2020
22 Jan 2020 Comment Pharmaceuticals contrasts travel and tourism following China’s coronavirus outbreak 22 Jan 2020
19 Dec 2019 Clinical Trials Analysis Psilocybin moves closer to becoming a licensed treatment for depression 19 Dec 2019
21 Jun 2019 Comment Climate change means fresh opportunities for pharmaceutical companies 21 Jun 2019
